Bioartificial Human Liver Therapy Trial Progressing
Vital Therapies Enrolls First Patients in Expansion of its U.S. Clinical Trial in Europe
14-Jun-2010 -
Vital Therapies, Inc. (VTI) announced that the first two subjects have been enrolled at King's College Hospital in London in the expansion of its SILVER (Stabilization In LiVER failure) clinical trial in Europe. The trial is evaluating whether VTI's biological cellular therapy product, ELAD(R), ...
clinical trials
Denmark
liver cells
+4